Glenmark Pharmaceuticals . Stock Dips - Underperforms Sector and Market on November 18, 2024

Glenmark Pharmaceuticals ., a leading player in the pharmaceuticals and drugs industry, saw a dip in its stock price on November 18, 2024. The company's stock lost -3.21% on this day, underperforming the sector by -2.31%. According to MarketsMOJO, a leading stock analysis and recommendation platform, the current call for Glenmark Pharmaceuticals . is 'Hold'. This suggests that investors should hold onto their existing shares of the company and not make any new investments at this time. The stock's performance on November 18, 2024 was volatile, with an intraday high of Rs 1581 (2.73%) and an intraday low of Rs 1492.6 (-3.01%). The moving averages for the stock show that it is currently higher than the 200 day moving average, but lower than the 5 day, 20 day, 50 day, and 100 day moving averages. In comparison to the overall market performance, Glenmark Pharmaceuticals .'s stock underperformed on November 18, 2024. While the stock's 1 day performance was -3.27%, the Sensex's performance was only -0.40%. Similarly, the stock's 1 month performance was -14.42%, while the Sensex's performance was -4.87%. Overall, Glenmark Pharmaceuticals . has had a challenging day in the stock market, with a dip in its stock price and underperformance compared to the sector and overall market. Investors are advised to hold onto their existing shares and monitor the company's performance closely.